 SOUTH SAN FRANCISCO, Calif., Nov. 22, 2021 GLOBE NEWSWIRE -- Aligos Therapeutics, Inc. Nasdaq: ALGS, a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that Lawrence M. Blatt, Ph.D., MBA, Chairman and CEO of Aligos, will present at the Piper Sandler 33r d Annual Virtual Healthcare Conference being held from November 30 - December 2, 2021. The Aligos management team will also participate in virtual investor 1x1 meetings during the conference. 